Cargando…
Sirt1 Activity in PBMCs as a Biomarker of Different Heart Failure Phenotypes
Heart Failure (HF) is a syndrome, which implies the existence of different phenotypes. The new categorization includes patients with preserved ejection fraction (HFpEF), mid-range EF (HFmrEF), and reduced EF (HFrEF) but the molecular mechanisms involved in these HF phenotypes have not yet been exhau...
Autores principales: | Conti, Valeria, Corbi, Graziamaria, Polito, Maria Vincenza, Ciccarelli, Michele, Manzo, Valentina, Torsiello, Martina, De Bellis, Emanuela, D’Auria, Federica, Vitulano, Gennaro, Piscione, Federico, Carrizzo, Albino, Di Pietro, Paola, Vecchione, Carmine, Ferrara, Nicola, Filippelli, Amelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700185/ https://www.ncbi.nlm.nih.gov/pubmed/33238655 http://dx.doi.org/10.3390/biom10111590 |
Ejemplares similares
-
Cardiac Rehabilitation Increases SIRT1 Activity and β-Hydroxybutyrate Levels and Decreases Oxidative Stress in Patients with HF with Preserved Ejection Fraction
por: Corbi, Graziamaria, et al.
Publicado: (2019) -
The anti-ageing molecule sirt1 mediates beneficial effects of cardiac rehabilitation
por: Russomanno, Giusy, et al.
Publicado: (2017) -
Opposite Response to Vitamin K Antagonists: A Report of Two Cases and Systematic Review of Literature
por: Conti, Valeria, et al.
Publicado: (2022) -
Adrenoreceptors and nitric oxide in the cardiovascular system
por: Conti, Valeria, et al.
Publicado: (2013) -
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction
por: Polito, Maria Vincenza, et al.
Publicado: (2020)